What is Check-Cap?
Check-Cap Ltd. is focused on advancing colorectal cancer screening through its non-invasive, ingestible capsule imaging device, C-Scan. This technology aims to provide a more patient-friendly alternative or complement to traditional colonoscopy by employing a low-dose X-ray capsule for colon imaging. The company's strategic direction has also evolved, with a pending merger involving MBody AI to integrate embodied AI workforce solutions, while continuing its core diagnostic research and development.
How much funding has Check-Cap raised?
Check-Cap has raised a total of $12M across 1 funding round:
Stock Offering
$12M
Stock Issuance/Offering (2015): $12M, investors not publicly disclosed
What's next for Check-Cap?
The recent major strategic investment signals a pivotal phase for Check-Cap, potentially enabling the acceleration of its C-Scan technology development and market penetration. The company's dual focus on medical diagnostics and emerging AI solutions suggests a strategy aimed at diversifying its technological portfolio and exploring new avenues for growth and innovation in both healthcare and advanced technology sectors.
See full Check-Cap company page
